PubRank

Evaluation of the Efficacy and Mechanisms of a Novel Intervention for Chronic Pain Tailored to People Living With HIV (STOMP)

Clinical Trial ID NCT03692611

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03692611

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006 21.56
2 Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997 18.10
3 Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997 15.12
4 Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 1997 13.47
5 Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010 11.99
6 Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2007 8.89
7 New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2003 8.25
8 Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011 7.17
9 Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 2013 6.47
10 HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A 1999 5.25
11 Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004 5.12
12 The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med 2015 4.75
13 Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry 2005 4.41
14 Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011 4.11
15 CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep 2016 3.70
16 Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005 3.67
17 Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010 3.26
18 Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol 2010 2.91
19 The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med 2010 2.71
20 An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011 2.39
21 Treatment of chronic non-cancer pain. Lancet 2011 2.30
22 Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 2000 2.18
23 Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev 2005 2.11
24 Cytokines, inflammation, and pain. Int Anesthesiol Clin 2007 2.01
25 Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A 2014 1.96
26 HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 2004 1.91
27 Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 2005 1.86
28 Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013 1.82
29 A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 2011 1.64
30 Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013 1.60
31 Prescription opioid analgesics increase the risk of depression. J Gen Intern Med 2013 1.37
32 Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012. Am J Prev Med 2015 1.36
33 Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry 2008 1.32
34 Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr 2012 1.27
35 Neuropathic pain and cytokines: current perspectives. J Pain Res 2013 1.26
36 Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief 2015 1.20
37 Improved single-copy assays for quantification of persistent HIV-1 viremia in patients on suppressive antiretroviral therapy. J Clin Microbiol 2014 1.18
38 Can quantitative sensory testing move us closer to mechanism-based pain management? Pain Med 2013 1.11
39 Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. Ann Neurol 2010 1.10
40 Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database. Am J Epidemiol 2013 1.06
41 CXCR4 signaling mediates morphine-induced tactile hyperalgesia. Brain Behav Immun 2010 1.05
42 Prescription long-term opioid use in HIV-infected patients. Clin J Pain 2012 1.05
43 Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med 2012 1.02
44 Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain 2010 1.00
45 Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays. J Clin Microbiol 2002 0.99
46 The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+ T Cells. J Infect Dis 2015 0.97
47 Pain is independently associated with impaired physical function in HIV-infected patients. Pain Med 2013 0.97
48 Ongoing pain despite aggressive opioid pain management among persons with HIV. Clin J Pain 2010 0.97
49 Opioid induced hypogonadism. BMJ 2010 0.96
50 Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med 2013 0.96
51 Substance abuse increases the risk of neuropathy in an HIV-infected cohort. Muscle Nerve 2012 0.96
52 The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study. J Acquir Immune Defic Syndr 2009 0.95
53 Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy. Antivir Ther 2012 0.90
54 Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA. J Clin Microbiol 2016 0.86
55 Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients. J Acquir Immune Defic Syndr 2015 0.86
56 Evidence for abnormal cytokine expression in Gulf War Illness: A preliminary analysis of daily immune monitoring data. BMC Immunol 2015 0.86
57 HIV infection and drugs of abuse: role of acute phase proteins. J Neuroinflammation 2013 0.85
58 Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. J Pain 2016 0.84
59 Temporal summation of pain as a prospective predictor of clinical pain severity in adults aged 45 years and older with knee osteoarthritis: ethnic differences. Psychosom Med 2014 0.83
60 Taxonomy of pain of the IASP. Pain 1988 0.83
61 HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo. J Virol 2015 0.83
62 Opioid use for noncancer pain and risk of myocardial infarction amongst adults. J Intern Med 2013 0.83
63 Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms. Ann Neurosci 2012 0.80
64 Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy. J Infect Dis 2015 0.80
65 Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV. AIDS Behav 2016 0.79
66 Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain. Front Microbiol 2016 0.78
67 Quantitative Evaluation of an Instrument to Identify Chronic Pain in HIV-Infected Individuals. AIDS Res Hum Retroviruses 2015 0.77
68 Insights into the mechanisms and the emergence of sex-differences in pain. Neuroscience 2016 0.77
69 The role of microglia in the pathobiology of neuropathic pain development: what do we know? Br J Anaesth 2017 0.76
70 Towards an HIV cure. J Int AIDS Soc 2014 0.76
71 Sex Differences in Pain. J Neurosci Res 2016 0.75
72 Detectable Viral Load May Be Associated with Increased Pain Sensitivity in Persons Living with HIV: Preliminary Findings. Pain Med 2017 0.75
73 Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review. Ann Intern Med 2017 0.75
74 IL-1β levels are associated with chronic multisite pain in people living with HIV. J Acquir Immune Defic Syndr 2017 0.75
75 Association of Leptin with Body Pain in Women. J Womens Health (Larchmt) 2016 0.75
76 IL-17 contributed to the neuropathic pain following peripheral nerve injury by promoting astrocyte proliferation and secretion of proinflammatory cytokines. Mol Med Rep 2016 0.75
77 Effect of CXCL12/CXCR4 signaling on neuropathic pain after chronic compression of dorsal root ganglion. Sci Rep 2017 0.75
78 Prescription opioid use in advanced COPD: benefits, perils and controversies. Eur Respir J 2017 0.75
79 Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: A Delphi Study. J Gen Intern Med 2017 0.75
80 Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host Microbe 2017 0.75
81 Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain 2015 0.75
82 Chronic pain disorders in HIV primary care: clinical characteristics and association with healthcare utilization. Pain 2016 0.75
83 Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. PLoS Pathog 2017 0.75
84 Optimizing measures of HIV-associated neuropathy. Muscle Nerve 2014 0.75
85 Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH). J Med Econ 2017 0.75
86 Sex differences in innate immunity and its impact on opioid pharmacology. J Neurosci Res 2017 0.75
87 Sex differences in the pro-inflammatory cytokine response to endotoxin unfold in vivo but not ex vivo in healthy humans. Innate Immun 2017 0.75
Next 100